Welcome to our dedicated page for Sylvamo SEC filings (Ticker: SLVM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Sylvamo Corporation filings document the reporting framework for a public uncoated papers company listed on the New York Stock Exchange under SLVM. Form 8-K reports include operating and financial results, material agreements, capital-structure disclosures, board changes, executive appointments and other material events.
The company’s proxy materials cover annual shareowner voting, director elections, auditor ratification, executive compensation and board governance. Recent filings also document common stock, preferred stock purchase rights, rights-agreement mechanics, governance arrangements and disclosure controls related to Sylvamo’s paper mills and regional operating model.
Sylvamo Corp director Christine S. Breves received a grant of 3,876 shares of common stock in the form of time-based restricted stock units. The grant was priced at $38.70 per share and increased her direct holdings to 19,076 shares.
The RSUs were awarded for service as a director for the 2026-2027 performance year. They will vest and settle one-for-one in common stock upon the earlier of May 13, 2027, or the next annual shareowners meeting, making this a compensation-related, not open-market, acquisition.
Sylvamo Corporation posted a weak first quarter of 2026, swinging to a small loss amid lower sales and margins. Net sales fell to $755 million from $821 million a year earlier, and the company reported a net loss of $3 million versus net income of $27 million in the prior-year quarter. Diluted earnings per share declined from $0.65 to $(0.08).
Profitability compressed sharply, with Adjusted EBITDA dropping to $29 million and margin sliding to 4%, down from $90 million and 11%. Europe moved deeper into operating losses, Latin America and North America both saw lower operating profit, and pricing, volume and higher operating and input costs all weighed on results.
Operating cash flow shifted to an outflow of $10 million compared with inflows of $23 million a year ago, and free cash flow was $(59) million versus $(25) million. Sylvamo still ended the quarter with $130 million of cash and total assets of $2.8 billion, and it paid $18 million in dividends.
Management describes 2026 as a transition year, citing short‑term capacity constraints from the end of the Riverdale supply agreement and an extended outage at the Eastover mill tied to strategic investments. In May 2026, the company refinanced its accounts receivable securitization and replaced its Term Loan F with a new $357 million Term Loan F‑3 maturing in 2032, also using proceeds to repay revolving credit borrowings, which extends its debt maturity profile.
Sylvamo Corporation reported a Q1 2026 net loss of $3 million as sales softened. Net sales were $755 million, down from $890 million in Q4 2025, and adjusted EBITDA was $29 million, a 4% margin, versus $125 million and a 14% margin in Q4.
Losses reflected lower volumes, weaker sales mix and higher operating and input costs across all regions, along with inventory builds during North American mill transitions. Free cash flow was negative $59 million as cash used in operations and $49 million of capital spending outweighed earnings. The company maintained a $0.45 quarterly dividend and refinanced debt due in 2027 while advancing its Eastover mill investment and lean transformation initiatives.
Zallie James P. reported acquisition or exercise transactions in this Form 4 filing.
Sylvamo Corp director James P. Zallie received additional stock-based compensation through dividend equivalents. He was granted 28.2209 Dividend Equivalent Units tied to prior restricted or deferred stock awards, at a reference price of $43.57 per unit. Following this award, he holds a total of 282.1069 such units, each representing the right to receive one share of common stock upon vesting under the plan’s original terms.
JOHNSON JOIA M reported acquisition or exercise transactions in this Form 4 filing.
Sylvamo Corp director Joia M. Johnson received 142.7574 deferred stock units as a grant tied to a dividend on the company’s common stock. These are dividend equivalent units credited under Sylvamo’s plan for non-employee directors and will vest on the same terms as the underlying awards.
After this grant, Johnson holds a total of 1,135.8436 deferred stock units, each representing the right to receive one share of Sylvamo common stock upon vesting.
Sylvamo Corp director Jeanmarie F. Desmond received additional equity-based compensation in the form of dividend equivalents. On this Form 4, she acquired 80.8092 deferred stock units tied to Sylvamo common stock, credited at a reference price of $43.57 per unit. These units are dividend equivalent units accrued on previously granted restricted stock units and/or deferred stock units under Sylvamo’s Restricted Stock and Deferred Compensation Plan for Non-Employee Directors. Each new unit represents the right, subject to vesting, to receive one share of common stock, bringing her total deferred stock unit balance to 507.9307 units.
Sylvamo Corp director David D. Petratis reported an acquisition of 305.5347 Deferred Stock Units (DEUs) on Sylvamo common stock at $43.57 per unit. According to the plan footnote, these DEUs were credited as dividend equivalents on previously granted RSUs and/or DSUs and will vest and settle on the same terms as those original awards. After this grant, Petratis directly holds 2,405.0802 Deferred Stock Units, each representing the right to receive, subject to vesting, one share of Sylvamo common stock.
Bruce Lizanne M reported acquisition or exercise transactions in this Form 4 filing.
Sylvamo Corp director Lizanne M. Bruce received an automatic compensation-related award of 28.2209 Dividend Equivalent Units (DEUs) on April 28, 2026. These DEUs were accrued on previously granted restricted stock units (RSUs) and/or deferred stock units (DSUs) in connection with a dividend paid on Sylvamo common stock.
Each DEU represents the right to receive, subject to vesting, one share of Sylvamo common stock and will vest and settle on the same terms as the underlying RSUs or DSUs. Following this grant, Bruce directly holds 282.1069 DEUs under Sylvamo’s Restricted Stock and Deferred Compensation Plan for Non-Employee Directors.
Breves Christine S reported acquisition or exercise transactions in this Form 4 filing.
Sylvamo Corp director Christine S. Breves received additional equity-based awards tied to her existing board compensation. She was granted 28.2209 Dividend Equivalent Units and 59.8013 Deferred Stock Units on 2026-04-28, reflecting dividend equivalents accrued on previously granted restricted and deferred stock units.
These units were credited at a reference price of $43.57 and each represents the right to receive, subject to vesting, one share of Sylvamo common stock. The new awards increase her direct holdings in these derivative units to 190.9069 Dividend Equivalent Units and 515.8936 Deferred Stock Units, which will vest and settle on the same terms as the original awards.
Sylvamo Corp senior vice president Patrick Wilczynski reported an acquisition of additional stock-based compensation tied to prior awards. He received 84.8345 Dividend Equivalent Units (DEUs) on April 28, 2026, accrued on restricted stock units (RSUs) previously granted to him.
Each DEU represents the right, subject to vesting, to receive one share of Sylvamo common stock on the same terms as the original RSUs. Following this grant, Wilczynski holds a total of 1,136.3072 DEUs, reflecting his accumulated dividend equivalents rather than an open-market share purchase.